Marc Beer is the face behind Renovia Incorporated, a medical facility he co-founded to address the prevailing problem of pelvic floor disorders among women. The primary aim of Renovia is to develop technology-based diagnosis and treatment approaches. Since its inception in 2016, Renovia has undertaken considerable steps, most of which have been geared towards achieving its ultimate goal of providing a reliable treatment to women with urinary incontinence and fecal incontinence and other associated pelvic floor disorders.
However, to achieve his dream, Marc Beer has had to work day and night to raise funds that will support the new med-tech facility. He has had to convince various investors that the new method of treatment will offer a turnaround to diseases that are currently affecting more than 250 million people around the world. Besides proving that his treatment approach will work, Marc has to convince various investors that they are investing in an investment opportunity that will generate immediate returns.
Despite the huge challenges experienced in raising funds, Marc Beer has been able to raise sufficient funds that will support his new invention. He has been able to raise $32 million with an additional $10 million, which will be in the form of venture funding. Therefore, Marc has a total of $42 million, which will be used to push his investment forward. His new invention seems to have attracted some of the most renowned companies in the industry, such as The Longwood Fund, Perceptive Advisors, among others, which is a clear indication that he has a positive response in the market.
Besides having the necessary funds to work and start the operations of the company, Marc Beer has received good news from the Food and Drug Administration (FDA). The Federal Government body has now approved his first medical product, Leva, which forms the basis for the treatment of pelvic floor disorders. Given that the new product has already been approved, Renovia will now go ahead and produce the product in masses because funds are available.
Marc is hoping to use the new technology at Renovia to improve the services offered to women diagnosed with pelvic floor disorders. The med-tech facility is creating a digital platform that will be used by women with pelvic floor disorders to understand their unique conditions, learn about the different treatment options in the industry, and lower the health costs by understanding pelvic floor disorders and associated conditions. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
About Marc Beer
Every person who has worked in the pharmaceutical and biomedical industry knows Marc Beer and his input in the medical sector. His knowledge of biomedical services and advanced medical equipment put him into the global scales. He is also an excellent person in marketing services where he spent a considerable period of his career marketing pharmaceutical and biomedical products.